Cerity Partners LLC Maxcyte, Inc. Transaction History

Cerity Partners LLC

$60.5 Billion
Q3 2025

A detailed history of Cerity Partners LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 30,672 shares of MXCT stock, worth $46,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,672

Holding current value

$46,314

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Oct 22, 2025	BUY	$1.27 - $2.33 $38,953 - $71,465	30,672 New	30,672 $48,000
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $46,161 - $66,928	12,510 New	12,510 $57,000

Others Institutions Holding MXCT

# of Institutions

119

Shares Held

70.8M

Call Options Held

Put Options Held

Cadian Capital Management, LP New York, NY

8.91M
Shares

$13.5 Million
1.1% of portfolio
Black Rock Inc. New York, NY

8.14M
Shares

$12.3 Million
0.0% of portfolio
Morgan Stanley New York, NY

7.03M
Shares

$10.6 Million
0.0% of portfolio
Mirabella Financial Services LLP London, X0

6.6M
Shares

$9.97 Million
1.57% of portfolio
Vanguard Group Inc Valley Forge, PA

5.6M
Shares

$8.46 Million
0.0% of portfolio

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $154M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account